Domingos J. Silva is an Intellectual Property Counsel in the Philadelphia office of Saul Ewing Arnstein & Lehr LLP.
Domingos’s practice spans patent prosecution, opinion work, and client counseling, and his clients include universities, start-ups, companies of various sizes, and venture funds.
He has extensive experience in the chemical, materials science, pharmaceutical, diagnostics, biotechnology, and biochemistry areas.
Domingos has a long professional history in the science field. After obtaining a Ph.D. in Organic Chemistry from Princeton and pursuing his post-doctorate fellowship work at MIT, Domingos embarked on a career as a research scientist for Incara Research Labs, and later as medicinal chemistry manager in the oncology and antibacterial programs for GlaxoSmithKline. As a medicinal chemist, Domingos co-authored 16 peer-reviewed publications, and was named as in inventor in 17 patent applications. At GlaxoSmithKline, he was a member of the development team for a novel kinase inhibitor, which was eventually approved by the FDA as an oral antitumor agent.
Domingos became a registered patent agent in 2009. Prior to joining Saul Ewing Arnstein & Lehr, Domingos worked for a boutique intellectual property firm and a large Philadelphia law firm. He is a member of American Chemical Society, AUTM, AIPLA, and Life Sciences PA. Domingos is admitted to practice in Pennsylvania and New Jersey, and before the U.S. Patent and Trademark Office.